The National Institute on Drug Abuse (NIDA) is offering this R01 grant to support comprehensive research aimed at the development of safe and effective medications for substance-related disorders (SRDs). This grant is specifically designed to accelerate translational discovery and development, encompassing both preclinical and/or clinical research projects. The ultimate purpose of this funding is to facilitate the progression of potential treatments closer to, or gaining, FDA approval. NIDA anticipates awarding approximately 10 grants, totaling $10,000,000, through this R01 mechanism. This initiative underscores NIDA’s commitment to combatting SRDs by bringing innovative and effective therapeutic options to those in need.
Opportunity ID: 51343
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-DA-10-018 |
Funding Opportunity Title: | Medications Development for Substance Related Disorders (R01) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Education Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.279 — Drug Abuse and Addiction Research Programs |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Jan 26, 2010 |
Last Updated Date: | – |
Original Closing Date for Applications: | Apr 29, 2010 |
Current Closing Date for Applications: | Apr 29, 2010 |
Archive Date: | May 30, 2010 |
Estimated Total Program Funding: | $10,000,000 |
Award Ceiling: | $1,000,000 |
Award Floor: | – |
Eligibility
Eligible Applicants: | Public housing authorities/Indian housing authorities County governments Native American tribal governments (Federally recognized) Private institutions of higher education City or township governments Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) State governments Public and State controlled institutions of higher education For profit organizations other than small businesses Small businesses Special district governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | Purpose. The National Institute on Drug Abuse (NIDA) is soliciting grant (R01) applications to support a diverse array of preclinical and/or clinical research projects that accelerate the translational discovery/development of safe and effective medications for the treatment of substance-related disorders (SRDs), with the ultimate goal of moving closer to, or gaining FDA approval of medications for the treatment of these disorders. Mechanism of Support. This FOA will utilize the R01 award mechanism. Funds Available and Anticipated Number of Awards. It is anticipated that a total of 10 awards will be funded for a total of $10,000,000. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-10-018.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
There are no related documents on this grant.
Packages
Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
93.279 | ADOBE-FORMS-B | Use for submissions intended for due dates of January 25, 2010 and beyond | PKG00016053 | Mar 29, 2010 | Apr 29, 2010 | View |
Package 1
Mandatory forms
51343 RR_SF424_1_2-1.2.pdf
51343 PerformanceSite_1_3-1.3.pdf
51343 RR_OtherProjectInfo_1_2-1.2.pdf
51343 RR_KeyPersonExpanded_1_2-1.2.pdf
51343 PHS398_CoverPageSupplement_1_4-1.4.pdf
51343 PHS398_ResearchPlan_1_3-1.3.pdf
51343 PHS398_Checklist_1_3-1.3.pdf
Optional forms
51343 PHS_CoverLetter_1_2-1.2.pdf
51343 PHS398_ModularBudget-1.1.pdf
51343 RR_Budget-1.1.pdf
51343 RR_SubawardBudget-1.2.pdf